Neuropace shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Neuropace by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $511k | 33k | 15.44 |
| 2025-09-30 | $206k | 20k | 10.31 |
| 2025-06-30 | $177k | 16k | 11.14 |
| 2025-03-31 | $312k | 25k | 12.29 |
| 2024-12-31 | $73k | 6.5k | 11.19 |
| 2024-09-30 | $29k | 4.2k | 6.97 |
| 2024-06-30 | $48k | 6.4k | 7.56 |
| 2024-03-31 | $28k | 2.1k | 13.20 |
| 2023-12-31 | $834 | 81 | 10.31 |
| 2023-09-30 | $719 | 74 | 9.73 |
| 2023-06-30 | $1.0k | 223 | 4.49 |
| 2022-12-31 | $101 | 68 | 1.49 |
| 2022-09-30 | $0 | 86 | 0.00 |
| 2022-06-30 | $0 | 43 | 0.00 |
| 2022-03-31 | $13k | 1.6k | 8.15 |
| 2021-12-31 | $41k | 4.1k | 10.07 |
| 2021-09-30 | $161k | 10k | 15.82 |
| 2021-06-30 | $243k | 10k | 23.77 |